# Progress Note 03 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Jane Austen (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN014-SYN
- Date: 2026-04-02
- Fictional facility: St. Posthumous Health Center
- Fictional author: Harriet Pemberton-Okafor, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Two-week review after starting replacement: electrolytes, cause, and autoimmune screening. **S**

## History of present illness

Ms. Austen returns two weeks after starting hydrocortisone and fludrocortisone. She has missed no doses. Within three days the morning nausea stopped and her appetite returned, and she now eats three meals a day. The lightheadedness on standing has almost gone, and the salt craving is less. She is still tired by late afternoon but has started writing again for an hour each morning. Her back ache is milder. She has practised with the trainer kit and can recite the sick-day rules. She has not yet ordered the medical ID. **S**

| Element | Detail |
|---|---|
| Replacement | Hydrocortisone 10 mg on waking and 5 mg at 2 pm; fludrocortisone 0.1 mg; no missed doses |
| Symptoms | Nausea gone; appetite back; afternoon tiredness; milder back ache |
| Weight | 53.4 kg, up 1.6 kg |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired by late afternoon; appetite good; no fevers or night sweats |
| Cardiovascular | Negative | No lightheadedness, palpitations, or ankle swelling |
| Gastrointestinal | Negative | No nausea, vomiting, or abdominal pain |
| Musculoskeletal | Positive | Mild low back ache by evening |
| Genitourinary | Negative | Periods regular |

5 systems reviewed. **S**

## Current medications

- Hydrocortisone 10 mg oral tablet, one tablet by mouth on waking **S**
- Hydrocortisone 5 mg oral tablet, one tablet by mouth at 2 pm **S**
- Fludrocortisone 0.1 mg oral tablet, one tablet by mouth each morning **S**
- Hydrocortisone 100 mg injection kit (with diluent), 100 mg into the thigh muscle once for vomiting, collapse or signs of adrenal crisis, then call 911 **S**

## Allergies

- No known allergy **S**

## Objective

BP 108/68 mmHg; pulse 80 bpm; respirations 14/min; temperature 36.8 °C; oxygen saturation 99% on room air; weight 53.4 kg; BMI 18.5 kg/m². All vital signs are synthetic.

Sodium: 137 mmol/L; Potassium: 4.6 mmol/L; Creatinine: 0.86 mg/dL; eGFR: 88 mL/min/1.73 m²; Glucose: 88 mg/dL; Hemoglobin: 11.9 g/dL (low); Eosinophils: 0.38 10*3/uL; 21-hydroxylase antibodies: 24 U/mL (high); Hemoglobin A1c: 5%; Tissue transglutaminase IgA: 0.8 U/mL; Total IgA: 188 mg/dL. All results are synthetic.

## Change since baseline

- Sodium: 131 mmol/L (low) at baseline, 137 mmol/L at this visit **S**
- Potassium: 5.4 mmol/L (high) at baseline, 4.6 mmol/L at this visit **S**
- Creatinine: 0.94 mg/dL at baseline, 0.86 mg/dL at this visit **S**
- eGFR: 79 mL/min/1.73 m² at baseline, 88 mL/min/1.73 m² at this visit **S**
- Glucose: 72 mg/dL at baseline, 88 mg/dL at this visit **S**
- Hemoglobin: 11.4 g/dL (low) at baseline, 11.9 g/dL (low) at this visit **S**
- Eosinophils: 0.74 10*3/uL (high) at baseline, 0.38 10*3/uL at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Brighter; weight 53.4 kg; blood pressure 108/68 seated |
| Skin and mouth | Pigmentation of the face, hands and gums unchanged so far |
| Lymph nodes | No palpable nodes |
| Abdomen | No enlarged liver or spleen |
| Extremities | No ankle edema |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Primary adrenal insufficiency (autoimmune Addison's disease)** (E27.1). 21-hydroxylase antibodies are positive (24 U/mL), so the cause is autoimmune adrenalitis; adrenal imaging and tuberculosis testing are not needed. She is responding well: nausea gone, weight up 1.6 kg, sodium 137 and potassium 4.6 mmol/L. Afternoon tiredness at two weeks is expected and does not by itself call for a higher dose. **S**
   - Continue hydrocortisone 10 mg and 5 mg and fludrocortisone 0.1 mg.
   - Order the medical ID today; sick-day rules stated back correctly.
   - Renin, electrolytes and blood count at the six-week visit.
2. **Mild normocytic anemia** (D64.9). Hemoglobin 11.9 g/dL, rising; eosinophils back to normal on hydrocortisone. **S**
   - Blood count again at six weeks.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Glucocorticoid dose: weight, energy, appetite, skin pigmentation, and signs of under- or over-replacement | Every visit | Completed today | Weight 53.4 kg, up 1.6 kg; appetite back; no signs of over-replacement; eosinophils 0.38 x10^3/uL, normal |
| Examination | Blood pressure lying and standing | Every visit | Deferred | Missed: blood pressure was taken seated only (108/68). No harm judging by her symptoms and electrolytes today and by the six-week visit, when there was no postural drop. Corrective action: lying and standing blood pressure added to her visit template |
| Laboratory | Mineralocorticoid: salt craving, edema, sodium and potassium | Before treatment, after any fludrocortisone change, then at least yearly | Completed today | Sodium 137, potassium 4.6 mmol/L; creatinine 0.86 mg/dL, eGFR 88; glucose 88 mg/dL |
| Laboratory | Plasma renin activity (with aldosterone at diagnosis) | At diagnosis; after any fludrocortisone change; then at least yearly, aiming for the upper normal range | Due | Six weeks after starting fludrocortisone |
| Self-management | Sick-day rules, emergency injection kit, steroid card, and medical ID | Every visit | Completed today | Rules stated back; practice injection on the trainer; kit and card with her; medical ID ordered today |
| Laboratory | Cause: 21-hydroxylase antibodies; adrenal CT and tuberculosis testing if negative | Once, at diagnosis | Completed today | Positive (24 U/mL): autoimmune adrenalitis; no adrenal imaging or tuberculosis testing needed |
| Examination | Differential for lymphoma: weight, fevers and night sweats, lymph nodes and spleen, LDH, chest X-ray | At diagnosis, then each visit until symptoms and weight have recovered on replacement | Completed today | Weight rising; no fevers or night sweats; no nodes or enlarged spleen |
| Laboratory | Associated autoimmune disease: TSH, vitamin B12, A1c, celiac serology, and menstrual history | At diagnosis, then TSH and the others yearly or with symptoms; FSH if periods change | Completed today | A1c 5.0%; tissue transglutaminase IgA 0.8 U/mL with total IgA 188 mg/dL; TSH and vitamin B12 normal at the first visit; periods regular: no associated disease found |
| Laboratory | Blood count for the normocytic anemia (with ferritin, vitamin B12 and folate at work-up) | Work-up at diagnosis; repeat after the underlying cause is treated (CMID); stop once normal | Completed today | Hemoglobin 11.9 g/dL, rising |

## Goal progress

- A diagnosis within one week of the first visit, with treatment started the same day if adrenal insufficiency is confirmed. Outcome by 2026-03-19: Cosyntropin test three days after the first visit; replacement started the same day. **S**
- No adrenal crisis and no emergency admission through the episode. In progress; target 2026-10-12. **S**
- Sodium and potassium normal, renin in the upper normal range, and no postural drop by the six-week visit. In progress; target 2026-04-30. **S**
- She can state the sick-day rules and give the emergency injection by the two-week visit. Outcome by 2026-04-02: Stated the rules and gave a practice injection on a trainer. **S**
- Weight back to her usual 57 kg, and energy for full mornings of writing, by six months. In progress; target 2026-10-12. **S**

## Guideline basis

- Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016), Endocrine Society (Journal of Clinical Endocrinology and Metabolism)
- CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026), Aether Forge
- American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease (2023), American College of Gastroenterology (American Journal of Gastroenterology)

## Follow-up

- Six-week visit with electrolytes, creatinine, renin, blood count, and lying and standing blood pressure. Follow the sick-day rules for any fever. **S**
- Next scheduled visit 2026-04-30: six-week review: electrolytes, renin, blood count, and recovery. **S**
